A0_Samples	A17_Age	A18_Sex	A19_Height	A1_OS	A20_Weight	A21_BMI	A22_histological_type	A23_Tumor_tissue_site	A2_Event	A3_T	A4_N	A5_M	A6_Stage	A8_New_Event	A8_New_Event_Time	A8_New_Event_Tissue	A8_New_Event_Type	A9_Cancer_Status	additional_studies	bcr_patient_barcode	bcr_patient_uuid	blood_relative_cancer_history_list.blood_relative_cancer_history.family_cancer_type_txt	blood_relative_cancer_history_list.blood_relative_cancer_history.family_member_relationship_type	cancer_first_degree_relative	day_of_form_completion	days_to_birth	days_to_death	days_to_last_followup	drugs.drug.bcr_drug_barcode	drugs.drug.bcr_drug_uuid	drugs.drug.clinical_trail_drug_classification	drugs.drug.day_of_form_completion	drugs.drug.days_to_drug_therapy_end	drugs.drug.days_to_drug_therapy_start	drugs.drug.drug_name	drugs.drug.measure_of_response	drugs.drug.month_of_form_completion	drugs.drug.number_cycles	drugs.drug.prescribed_dose	drugs.drug.prescribed_dose_units	drugs.drug.regimen_indication	drugs.drug.regimen_indication_notes	drugs.drug.regimen_number	drugs.drug.route_of_administrations.route_of_administration	drugs.drug.therapy_ongoing	drugs.drug.therapy_types.therapy_type	drugs.drug.therapy_types.therapy_type_notes	drugs.drug.total_dose	drugs.drug.total_dose_units	drugs.drug.tx_on_clinical_trial	drugs.drug.year_of_form_completion	eastern_cancer_oncology_group	ethnicity	follow_ups.follow_up.bcr_followup_barcode	follow_ups.follow_up.bcr_followup_uuid	follow_ups.follow_up.day_of_form_completion	follow_ups.follow_up.days_to_death	follow_ups.follow_up.days_to_last_followup	follow_ups.follow_up.lost_follow_up	follow_ups.follow_up.month_of_form_completion	follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy	follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_radiation_therapy	follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure	follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment	follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_transplant	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_occurrence_anatomic_site	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_type	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_occurrence_anatomic_site_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_event_ablation_embo_tx	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_event_liver_transplant	follow_ups.follow_up.new_tumor_events.new_tumor_event.residual_disease_new_tumor_event	follow_ups.follow_up.new_tumor_events.new_tumor_event_after_initial_treatment	follow_ups.follow_up.person_neoplasm_cancer_status	follow_ups.follow_up.post_op_ablation_embolization_tx	follow_ups.follow_up.postoperative_rx_tx	follow_ups.follow_up.radiation_therapy	follow_ups.follow_up.vital_status	follow_ups.follow_up.year_of_form_completion	gender	height	history_hepato_carcinoma_risk_factors.hist_hepato_carc_fact	history_hepato_carcinoma_risk_factors.hist_hepato_carcinoma_risk	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	month_of_form_completion	new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy	new_tumor_events.new_tumor_event.additional_radiation_therapy	new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure	new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment	new_tumor_events.new_tumor_event.days_to_new_tumor_event_transplant	new_tumor_events.new_tumor_event.new_neoplasm_event_occurrence_anatomic_site	new_tumor_events.new_tumor_event.new_neoplasm_event_type	new_tumor_events.new_tumor_event.new_neoplasm_occurrence_anatomic_site_text	new_tumor_events.new_tumor_event.new_tumor_event_ablation_embo_tx	new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure	new_tumor_events.new_tumor_event.new_tumor_event_liver_transplant	new_tumor_events.new_tumor_event.residual_disease_new_tumor_event	new_tumor_events.new_tumor_event_after_initial_treatment	other_dx	patient_id	person_neoplasm_cancer_status	post_op_ablation_embolization_tx	postoperative_rx_tx	primary_pathology.age_at_initial_pathologic_diagnosis	primary_pathology.albumin_result_lower_limit	primary_pathology.albumin_result_specified_value	primary_pathology.albumin_result_upper_limit	primary_pathology.bilirubin_lower_limit	primary_pathology.bilirubin_upper_limit	primary_pathology.ca_19_9_level	primary_pathology.ca_19_9_level_lower	primary_pathology.ca_19_9_level_upper	primary_pathology.child_pugh_classification_grade	primary_pathology.cholangitis_tissue_evidence	primary_pathology.creatinine_lower_level	primary_pathology.creatinine_upper_limit	primary_pathology.creatinine_value_in_mg_dl	primary_pathology.days_to_initial_pathologic_diagnosis	primary_pathology.fetoprotein_outcome_lower_limit	primary_pathology.fetoprotein_outcome_upper_limit	primary_pathology.fetoprotein_outcome_value	primary_pathology.fibrosis_ishak_score	primary_pathology.histological_type	primary_pathology.history_prior_surgery_type_other	primary_pathology.inter_norm_ratio_lower_limit	primary_pathology.intern_norm_ratio_upper_limit	primary_pathology.neoplasm_histologic_grade	primary_pathology.perineural_invasion_present	primary_pathology.platelet_result_count	primary_pathology.platelet_result_lower_limit	primary_pathology.platelet_result_upper_limit	primary_pathology.prothrombin_time_result_value	primary_pathology.residual_tumor	primary_pathology.specimen_collection_method_name	primary_pathology.total_bilirubin_upper_limit	primary_pathology.tumor_tissue_site	primary_pathology.vascular_tumor_cell_type	primary_pathology.year_of_initial_pathologic_diagnosis	race_list.race	radiation_therapy	radiations.radiation.anatomic_treatment_site	radiations.radiation.bcr_radiation_barcode	radiations.radiation.bcr_radiation_uuid	radiations.radiation.course_number	radiations.radiation.day_of_form_completion	radiations.radiation.days_to_radiation_therapy_end	radiations.radiation.days_to_radiation_therapy_start	radiations.radiation.measure_of_response	radiations.radiation.month_of_form_completion	radiations.radiation.numfractions	radiations.radiation.radiation_dosage	radiations.radiation.radiation_treatment_ongoing	radiations.radiation.radiation_type	radiations.radiation.radiation_type_notes	radiations.radiation.regimen_indication	radiations.radiation.regimen_indication_notes	radiations.radiation.units	radiations.radiation.year_of_form_completion	relative_family_cancer_history	stage_event.ann_arbor.b_symptoms	stage_event.ann_arbor.extranodal_involvement	stage_event.clinical_stage	stage_event.gleason_grading.gleason_score	stage_event.gleason_grading.primary_pattern	stage_event.gleason_grading.secondary_pattern	stage_event.gleason_grading.tertiary_pattern	stage_event.igcccg_stage	stage_event.masaoka_stage	stage_event.pathologic_stage	stage_event.psa.days_to_psa	stage_event.psa.psa_value	stage_event.serum_markers	stage_event.system_version	stage_event.tnm_categories.clinical_categories.clinical_M	stage_event.tnm_categories.clinical_categories.clinical_N	stage_event.tnm_categories.clinical_categories.clinical_T	stage_event.tnm_categories.pathologic_categories.pathologic_M	stage_event.tnm_categories.pathologic_categories.pathologic_N	stage_event.tnm_categories.pathologic_categories.pathologic_T	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	vital_status	weight	year_of_form_completion
TCGA-W5-AA2Q	68	MALE	165	50	67	24.609733700642792	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T2b	N0	M0	Stage II	0	50			TUMOR FREE		TCGA-W5-AA2Q	F47DBD99-920B-4B39-A1B0-6C152AD24884	Bone cancer	Mother	1	23	-25069	Not Applicable	50																								0	NOT HISPANIC OR LATINO	TCGA-W5-AA2Q-F66605	E4C193F4-99F7-450E-B866-6BF4F88EB3AE	21	Not Available	50	YES	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	165	Smoking	Not Available	No	C22.1	8160/3	C22.1	YES	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	AA2Q	TUMOR FREE	NO	NO	68	3.4	3.7	4.7	0.1	1.4	247	0	55	A	None	0.9	1.4	1.0	0	0	6.0	4.3	1,2 - Portal Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	8.4	12.0	G2	NO	174	150	450	9.3	R0	Extended Lobectomy	1.0	Bile duct	None	2006	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	NO	YES	W5	Alive	67	2014
TCGA-W5-AA2O	57	MALE	167	640	73	26.175194521137367	Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T1	N0	M0	Stage I	1	215.0	Liver	Intrahepatic Recurrence	WITH TUMOR		TCGA-W5-AA2O	180A2B9C-9CAC-4D96-86E8-CD6B3B9386B5	Not Available	Not Available	Not Available	23	-21118	640	Not Available																								0	NOT HISPANIC OR LATINO																											MALE	167	Smoking	Not Available	No	C22.1	8160/3	C22.1	YES	5	Unknown	Unknown	Not Available	215	Not Available	Liver	Intrahepatic Recurrence	Not Available	Unknown	NO	NO	Not Available	YES	No	AA2O	WITH TUMOR	NO	NO	57	3.5	4.1	5.0	0.0	0.4	34	0	55	A	None	0.9	1.4	1.1	0	0	6.0	3.5	0 - No Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	0.8	1.2	G3	NO	150	150	450	0.8	R0	Extended Lobectomy	0.3	Bile duct	None	2006	WHITE	NO																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	W5	Dead	73	2014
TCGA-W5-AA39	81	MALE	176	170	80	25.826446280991735	Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T2	N0	M0	Stage II	0	170			WITH TUMOR		TCGA-W5-AA39	32E9558C-946B-4288-91E1-504E47C308AC	cervical cancer;lung cancer	Mother;Father	2	27	-29594	170	Not Available																								1	NOT HISPANIC OR LATINO																											MALE	176	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	AA39	WITH TUMOR	NO	NO	81	3.5	3.5	5.0	0.1	0.6	57	0	55	A	None	0.8	1.3	1.1	0	0	6.0	2.7	0 - No Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	0.9	1.2	G4	NO	350	150	450	1.2	RX	Lobectomy	1.0	Bile duct	None	2010	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	W5	Dead	80	2014
TCGA-W6-AA0S	46	FEMALE	144	808	61	29.417438271604937	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T1	N0	MX	Stage I	1	549.0	Non-regional / Distant Lymph Nodes	Extrahepatic Recurrence	TUMOR FREE		TCGA-W6-AA0S	7047DC12-E2ED-40B7-86FD-C5C53A2766FD	Not Available	Not Available	Not Available	16	-16951	Not Applicable	352	TCGA-W6-AA0S-D63756;TCGA-W6-AA0S-D63757	34FB284E-B734-425F-98DF-D68EF9C1F50E;DF535530-2DF1-4053-8A39-318CC6AE4CE3	Not Available;Not Available	16;16	123;123	33;33	gemcitabine;cisplatin	Unknown;Unknown	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	0	HISPANIC OR LATINO	TCGA-W6-AA0S-F67141;TCGA-W6-AA0S-F72745	65210943-40EA-43C8-BDA7-EC6C1D3C1049;D14FE876-2956-4BFF-B80B-0144F763B453	31;24	Not Available;Not Available	549;808	NO;NO	10;11	Unknown;Not Available	NO;Not Available	Not Available;Not Available	549;Not Available	Not Available;Not Available	Non-regional / Distant Lymph Nodes;Not Available	Extrahepatic Recurrence;Not Available	Not Applicable;Not Applicable	NO;Not Available	NO;Not Available	NO;Not Available	Not Available;Not Available	YES;Unknown	WITH TUMOR;Not Available	NO;NO	YES;YES	NO;NO	Alive;Alive	2014;2015	FEMALE	144	Diabetes mellitus;Non-Alcoholic Fatty Liver Disease	Not Available	No	C22.1	8160/3	C22.1	YES	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	AA0S	TUMOR FREE	NO	YES	46	3.5	4.0	4.8	0.2	0.3	Not Available	0	36	A	None	0.5	1.0	0.6	0	0	8	Not Available	1,2 - Portal Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	0.9	1.2	G2	YES	267	140	450	1.0	R0	Extended Lobectomy	1.3	Bile duct	None	2013	WHITE	NO																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	YES	NO	W6	Alive	61	2014
TCGA-3X-AAVE	60	MALE	160	650	59	23.046875	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T2	N0	M0	Stage II	0	650			TUMOR FREE		TCGA-3X-AAVE	DCC87C59-FD8C-4511-9983-96D5B9784CB0	Not Available	Not Available	Not Available	14	-21943	Not Applicable	203																								0	NOT HISPANIC OR LATINO	TCGA-3X-AAVE-F67115;TCGA-3X-AAVE-F72744	5F7D69A6-449F-47D4-B44D-E8239134CC12;A4A143BD-B0EF-41B8-84C4-A04FE47C39B3	30;24	Not Available;Not Available	309;650	NO;NO	10;11	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	NO;NO	NO;NO	Alive;Alive	2014;2015	MALE	160	Hepatitis B;Smoking	Not Available	No	C22.1	8160/3	C22.1	YES	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	AAVE	TUMOR FREE	NO	NO	60	3.3	4	4.8	0	1	Not Available	Not Available	Not Available	A	None	0.6	1.4	0.9	0	0	10	3.6	3,4 - Fibrous Speta	Cholangiocarcinoma; intrahepatic	Not Available	0.9	1.1	G2	NO	233	150	400	0.9	R0	Segmentectomy, Single	1.4	Bile duct	Micro	2013	ASIAN	NO																			Unknown	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	3X	Alive	59	2014
TCGA-W5-AA2I	66	MALE	178	1939	125	39.4520893826537	Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T1	N0	M0	Stage I	1	217.0	Other, specify	New Primary Tumor	WITH TUMOR		TCGA-W5-AA2I	3C8CA064-A4A7-416F-A069-4324D4A72038	Not Available	Not Available	Not Available	22	-24388	1939	Not Available																								0	NOT HISPANIC OR LATINO																											MALE	178	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	5	YES	YES	226	217	Not Available	Other, specify	New Primary Tumor	bladder	NO	YES	NO	R1	YES	No	AA2I	WITH TUMOR	NO	NO	66	3.5	4.4	5.0	0.1	0.7	296	0	40	A	None	0.9	1.4	1.4	0	0	6.0	2.9	0 - No Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	0.9	1.2	G2	NO	138	150	450	1.1	R0	Segmentectomy, Multiple	1.0	Bile duct	None	2005	WHITE	NO																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	W5	Dead	125	2014
TCGA-ZD-A8I3	73	FEMALE	152	169	49	21.208448753462605	Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T2	N0	M0	Stage II	1	59.0	Liver	Locoregional Recurrence	TUMOR FREE		TCGA-ZD-A8I3	CCB028AE-777C-4AF6-B92E-40848F1CF774	Not Available	Not Available	Not Available	29	-26754	Not Applicable	0																								3	NOT HISPANIC OR LATINO	TCGA-ZD-A8I3-F69616	80C94EAD-0D69-455D-9604-8D6D8A466EDD	15	169	Not Available	NO	1	NO	NO	Not Available	59	Not Available	Liver	Locoregional Recurrence	Not Applicable	NO	NO	NO	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	FEMALE	152	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A8I3	TUMOR FREE	Unknown	Unknown	73	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Cholangiocarcinoma; intrahepatic	Not Available	Not Available	Not Available	G3	Unknown	Not Available	Not Available	Not Available	Not Available	R0	Lobectomy	Not Available	Bile duct	Unknown	2013	ASIAN	Unknown																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	ZD	Alive	49	2014
TCGA-4G-AAZG	75	MALE	Not Available	1716	Not Available		Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T3	N0	MX	Stage III	0	1716			TUMOR FREE		TCGA-4G-AAZG	C60EB7BE-C85C-4338-A20B-51948D43BF2A	Not Available	Not Available	Not Available	25	-27490	Not Applicable	1716																								0	NOT HISPANIC OR LATINO																											MALE	Not Available	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Yes	AAZG	TUMOR FREE	NO	NO	75	3.5	3.6	4.5	.1	1.3	166.7	0	35	Not Applicable	None	.6	1.3	1.1	0	0	9	2	1,2 - Portal Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	.8	1.2	G2	NO	189000	15000	450000	1.1	R0	Lobectomy	1.2	Bile duct	None	2011	WHITE	NO																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage III	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	NO	YES	4G	Alive	Not Available	2015
TCGA-ZH-A8Y5	69	MALE	175	1229	85	27.755102040816325	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T3	N1	M1	Stage IVB	1	242.0	Lung	Extrahepatic Recurrence	WITH TUMOR		TCGA-ZH-A8Y5	9D9109F5-5917-4126-8E34-8A7E4632E913	Breast	Sister	1	11	-25268	Not Applicable	707	TCGA-ZH-A8Y5-D57466;TCGA-ZH-A8Y5-D57467	4F0CFB1E-6B24-47EE-A71F-5A949E02D46E;BDEA6737-0E80-4FE9-AA9C-4B0D215895A0	Not Available;Not Available	11;11	246;231	132;132	Gemzar;Cisplatin	Partial Response;Partial Response	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	0	NOT HISPANIC OR LATINO	TCGA-ZH-A8Y5-F70049;TCGA-ZH-A8Y5-F72746	0E6B803E-33E8-47C6-B321-A976E908D40F;5B862758-E6EA-424C-B6A2-A61E34390940	26;20	Not Available;Not Available	1015;1229	NO;NO	1;11	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	YES;YES	NO;NO	Alive;Alive	2015;2015	MALE	175	Smoking	Not Available	No	C22.1	8160/3	C22.1	YES	3	YES	NO	Not Available	242	Not Available	Lung	Extrahepatic Recurrence	Not Available	NO	NO	Not Available	Not Available	YES	No	A8Y5	WITH TUMOR	NO	YES	69	3.5	4.3	5.0	0.0	0.7	7	Not Available	55	Not Available	Not Available	0.7	1.3	1.0	0	Not Available	Not Available	Not Available	Not Available	Cholangiocarcinoma; intrahepatic	Not Available	Not Available	Not Available	G3	NO	269000	150000	440000	1.0	R0	Segmentectomy, Multiple	1.2	Bile duct	Micro	2012	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1	N1	T3	YES	NO	ZH	Alive	85	2014
TCGA-W5-AA2K	75	FEMALE	164	833	68	25.28256989886972	Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T1	N0	M0	Stage I	0	833			Unknown		TCGA-W5-AA2K	859ED2D9-668D-440C-86AB-DCD0D9742973	Not Available	Not Available	Not Available	25	-27718	833	Not Available																								0	NOT HISPANIC OR LATINO																											FEMALE	164	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	AA2K	Unknown	NO	NO	75	3.5	4.4	5	.1	.8	2560	0	55	A	None	.6	1.1	.7	0	0	6	Not Available	0 - No Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	.8	1.2	G3	NO	208	150	450	1	R0	Lobectomy	1	Bile duct	None	2008	WHITE	NO																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	W5	Dead	68	2015
TCGA-W5-AA38	55	FEMALE	168	1471	73	25.864512471655328	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T1	N0	M0	Stage I	1	377.0	Liver	Locoregional Recurrence	TUMOR FREE		TCGA-W5-AA38	48D17B17-348C-405A-AE92-F190372A3AAC	colorectal cancer	Mother	1	27	-20285	Not Applicable	964																								1	NOT HISPANIC OR LATINO	TCGA-W5-AA38-F72741	487533AD-A533-4E42-B5C3-0FC758FF80B7	23	Not Available	1471	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE	NO	NO	NO	Alive	2015	FEMALE	168	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	5	YES	NO	Not Available	377	Not Available	Liver	Locoregional Recurrence	Not Available	NO	YES	NO	R0	YES	No	AA38	TUMOR FREE	NO	NO	55	3.5	4.8	5.0	0.1	0.3	199	0	55	A	None	0.6	1.1	0.6	0	0	6.0	2.2	1,2 - Portal Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	0.8	1.2	G3	NO	239	150	450	1.0	R0	Lobectomy	1.0	Bile duct	None	2011	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	W5	Alive	73	2014
TCGA-W5-AA34	75	FEMALE	160	555	71	27.734375	Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T1	N0	M0	Stage I	1	40.0	Liver	Intrahepatic Recurrence	WITH TUMOR		TCGA-W5-AA34	ADC9A685-5B4A-4C29-881A-DA1895C47520	Stomach cancer;Prostate and colon cancer;lung cancer;non-invasive ductal carcinoma in situ of the breast	Mother;Father;Sister;Sister	4	27	-27535	Not Applicable	168																								1	NOT HISPANIC OR LATINO	TCGA-W5-AA34-F66612	21FCE0D1-DDBF-4A40-9D2F-E1C28CE88E1A	21	555	Not Available	NO	10	NO;YES	NO;NO	Not Available;Not Available	40;152	Not Available;Not Available	Liver;Liver	Intrahepatic Recurrence;Intrahepatic Recurrence	Not Applicable;Not Applicable	YES;NO	Not Available;Not Available	NO;NO	Not Available;Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2014	FEMALE	160	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	5	NO;YES	NO;NO	Not Available;Not Available	40;152	Not Available;Not Available	Liver;Liver	Intrahepatic Recurrence;Intrahepatic Recurrence	Not Available;Not Available	YES;NO	NO;NO	NO;NO	Not Available;Not Available	YES	No	AA34	WITH TUMOR	NO	NO	75	3.5	4.2	5.0	0.1	0.4	25	0	55	A	None	0.6	1.1	0.6	0	0	6.0	2.5	0 - No Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	0.8	1.2	G2	NO	203	150	450	1.0	R0	Segmentectomy, Single	1.0	Bile duct	None	2012	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	W5	Alive	71	2014
TCGA-W7-A93P	Not Available	FEMALE	165	1777	93	34.15977961432507	Cholangiocarcinoma; distal	Bile duct	Alive	T3	N0	MX	Stage IIB	0	1777			TUMOR FREE		TCGA-W7-A93P	AE8D1ED6-2DDF-47B0-8099-BBC9230B499E	Not Available	Not Available	Not Available	25	Not Available	Not Applicable	1777																								Not Available	NOT HISPANIC OR LATINO																											FEMALE	165	Diabetes mellitus	Not Available	No	C24.0	8160/3	C24.0	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A93P	TUMOR FREE	NO	YES	Not Available	Not Available	Not Available	Not Available	13	84	91	5	7	Not Applicable	Not Evaluated	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Cholangiocarcinoma; distal	Not Available	Not Available	Not Available	G2	YES	431	345	439	1.4	R0	Pancreaticoduodenectomy (Whipple Resection)	96	Bile duct	None	2010	WHITE	NO																			Unknown	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	NO	YES	W7	Alive	93	2015
TCGA-ZH-A8Y8	73	MALE	183	602	98	29.263340201260114	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T1	N0	M0	Stage I	0	602			TUMOR FREE		TCGA-ZH-A8Y8	5CF3911A-F3EA-4C0E-851D-5BB57CA7190F	Thyroid;Lung	Sister;Sister	2	11	-26744	Not Applicable	104																								Not Available	NOT HISPANIC OR LATINO	TCGA-ZH-A8Y8-F68806;TCGA-ZH-A8Y8-F72747	F3C7DA1C-55A2-4E15-B9D0-47767B5968D2;D0AB38D7-13F5-4D5D-A84B-79B56C0C8BB7	17;24	Not Available;Not Available	409;602	NO;NO	12;11	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	NO;NO	NO;NO	Alive;Alive	2014;2015	MALE	183	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Yes	A8Y8	TUMOR FREE	NO	NO	73	Not Available	Not Available	Not Available	0.0	0.7	39.2	0.0	36.9	Not Available	Not Available	0.7	1.0	0.8	0	Not Available	Not Available	Not Available	Not Available	Cholangiocarcinoma; intrahepatic	Not Available	Not Available	Not Available	G2	YES	261000	150000	440000	1.1	R0	Lobectomy	1.2	Bile duct	None	2013	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	YES	NO	ZH	Alive	98	2014
TCGA-WD-A7RX	71	FEMALE	147	21	51	23.601277245592115	Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T2b	NX	MX	Stage II	0	21			TUMOR FREE		TCGA-WD-A7RX	4290B3B3-94F6-43E4-8309-430DD973AE2D	multiple myeloma	Mother	1	23	-26006	21	Not Available																								0	HISPANIC OR LATINO																											FEMALE	147	Cirrhosis;Diabetes mellitus;Smoking	Not Available	No	C22.0	8160/3	C22.0	YES	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7RX	TUMOR FREE	NO	NO	71	3.5	3.7	4.8	0.3	0.6	34	0	37	Unknown	Not Evaluated	0.40	1.00	0.9	0	0	8.1	2.6	3,4 - Fibrous Speta	Cholangiocarcinoma; intrahepatic	Right Hepatectomy	10.4	13.1	G2	Unknown	156	150	400	12.2	RX	Other (specify)	1.2	Bile duct	None	2013	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2b	YES	NO	WD	Dead	51	2013
TCGA-4G-AAZO	71	FEMALE	161	1177	67	25.847768218818718	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T2a	N0	M0	Stage II	1	424.0	Liver	Intrahepatic Recurrence	WITH TUMOR		TCGA-4G-AAZO	0775583E-C0A0-4F18-9CA2-8F89CEDCE3D6	Not Available	Not Available	Not Available	26	-25989	Not Applicable	609	TCGA-4G-AAZO-D62167	DA3CDAE0-3E09-4885-85DD-D56EDBA4AAC1	Not Available	26	Not Available	427	GEMCITABINE	Stable Disease	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	NOT HISPANIC OR LATINO	TCGA-4G-AAZO-F72742	A1F80603-EDE6-46BE-93BA-E2F67DBEFE2D	10	Not Available	1177	NO	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	NO	YES	NO	Alive	2015	FEMALE	161	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	7	YES	NO	Not Available	424	Not Available	Liver	Intrahepatic Recurrence	Not Available	NO	NO	NO	Not Available	YES	No	AAZO	WITH TUMOR	NO	YES	71	3.4	3.8	4.8	0.3	0.7	6	0	35.0	Unknown	None	0.6	1.1	0.9	0	0	9.0	2.4	1,2 - Portal Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	10	13	G2	NO	164000	140000	450000	11.6	R1	Segmentectomy, Multiple	1.2	Bile duct	None	2012	WHITE	NO																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	NO	YES	4G	Alive	67	2014
TCGA-W5-AA2U	78	FEMALE	156	627	60	24.65483234714004	Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T1	N0	M0	Stage I	1	95.0	Lung	New Primary Tumor	WITH TUMOR		TCGA-W5-AA2U	AAACF22C-2362-4613-B024-88FB7DD1CCA1	Unknown	Sister	1	24	-28552	627	Not Available																								1	NOT HISPANIC OR LATINO																											FEMALE	156	Smoking	Not Available	No	C22.1	8160/3	C22.1	YES	5	NO	NO	Not Available	95	Not Available	Lung	New Primary Tumor	Not Available	NO	NO	NO	Not Available	YES	No	AA2U	WITH TUMOR	NO	NO	78	3.5	4.5	5.0	0.1	0.7	91	0	55	A	None	0.6	1.1	0.8	0	Not Available	Not Available	Not Available	0 - No Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	0.9	1.2	G3	NO	305	150	450	1.0	R0	Segmentectomy, Multiple	1.0	Bile duct	None	2010	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	W5	Dead	60	2014
TCGA-4G-AAZR	74	MALE	Not Available	28	Not Available		Cholangiocarcinoma; hilar/perihilar	Bile duct	Dead	T2a	N0	MX	Stage II	0	28			Not Available		TCGA-4G-AAZR	57500D4C-4BB3-4F32-AE3A-A0B78F18C526	Not Available	Not Available	Not Available	25	-27151	28	Not Available																								0	NOT HISPANIC OR LATINO																											MALE	Not Available	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	AAZR	Not Available	NO	NO	74	3.5	3.9	4.5	.1	2	Not Available	0	35	Not Applicable	None	.6	1.3	1.1	0	0	9	Not Available	0 - No Fibrosis	Cholangiocarcinoma; hilar/perihilar	Bile duct resction with anastomosis plus lobectomy	.8	1.2	G2	NO	178000	15000	450000	1.2	R1	Other (specify)	1.2	Bile duct	None	2013	WHITE	NO																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	NO	YES	4G	Dead	Not Available	2015
TCGA-W5-AA2T	64	FEMALE	155	1220	62	25.806451612903224	Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T2	N0	M0	Stage II	1	295.0	Bone	Extrahepatic Recurrence	WITH TUMOR		TCGA-W5-AA2T	8944FE2A-E32F-4898-A2C5-FB6751F602A4	Not Available	Not Available	Not Available	24	-23560	1220	Not Available	TCGA-W5-AA2T-D59942	240B497B-AD30-49EC-959C-FB016B32EE77	Not Available	24	205	56	Gemcitabine	Complete Response	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	NOT HISPANIC OR LATINO																											FEMALE	155	Smoking	Not Available	No	C22.1	8160/3	C22.1	YES	5	YES;YES;YES;NO	YES;YES;NO;YES	296;907;Not Available;1021	295;561;896;993	Not Available;Not Available;Not Available;Not Available	Bone;Bone;Lung;Bone	Extrahepatic Recurrence;Extrahepatic Recurrence;Extrahepatic Recurrence;Extrahepatic Recurrence	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	YES;YES;NO;YES	NO;NO;NO;NO	R0;RX;Not Available;RX	YES	Yes	AA2T	WITH TUMOR	NO	YES	64	3.5	4.4	5.0	0.1	0.4	33	0	55	A	None	0.6	1.1	0.6	0	Not Available	Not Available	Not Available	0 - No Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	0.8	1.2	G3	NO	274	150	450	1.0	R0	Extended Lobectomy	1.0	Bile duct	None	2008	WHITE	NO																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	W5	Dead	62	2014
TCGA-ZU-A8S4	52	MALE	183	98	122	36.42987249544627	Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T1	NX	MX	Stage I	1	72.0	Liver	Intrahepatic Recurrence	WITH TUMOR		TCGA-ZU-A8S4	E76CF9A0-061E-4A7D-BA28-5A40B8DA54B8	Not Available	Not Available	Not Available	8	-19264	98	Not Available																								Unknown	NOT HISPANIC OR LATINO																											MALE	183	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	72;72	Not Available;Not Available	Liver;Other, specify	Intrahepatic Recurrence;Extrahepatic Recurrence	Not Available;mesentery, Gerota's fascia, extensive involvement in chest	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES	No	A8S4	WITH TUMOR	NO	YES	52	3.5	4.2	5.0	0.2	0.4	115	0	35.0	Unknown	Not Evaluated	0.60	1.30	0.9	0	0	8.0	1.9	0 - No Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	0.9	1.2	G3	YES	279	140	400	1.1	R0	Lobectomy	1.0	Bile duct	None	2012	WHITE	NO																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	ZU	Dead	122	2014
TCGA-3X-AAVA	50	FEMALE	Not Available	445	92		Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T2b	NX	M0	Stage II	1	265.0	Liver	Intrahepatic Recurrence	WITH TUMOR		TCGA-3X-AAVA	FE57B639-DB7A-460F-ADFE-552F1E034E46	Not Available	Not Available	Not Available	2	-18303	445	Not Available																								1	NOT HISPANIC OR LATINO																											FEMALE	Not Available	Diabetes mellitus;Smoking	Not Available	No	C22.1	8160/3	C22.1	YES	9	NO;NO;NO	NO;YES;NO	Not Available;Not Available;Not Available	265;264;264	Not Available;Not Available;Not Available	Liver;Bone;Bone	Intrahepatic Recurrence;Extrahepatic Recurrence;Extrahepatic Recurrence	Not Available;Not Available;Not Available	NO;NO;NO	NO;NO;NO	NO;NO;NO	Not Available;Not Available;Not Available	YES	No	AAVA	WITH TUMOR	NO	NO	50	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	None	0.4	1.1	0.5	0	0	10	5.4	1,2 - Portal Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	Not Available	Not Available	G2	YES	214	150	400	Not Available	R0	Segmentectomy, Single	Not Available	Bile duct	None	2012	WHITE	NO	Distant Recurrence	TCGA-3X-AAVA-R64408	69454CCD-16F1-4E8A-8BD3-218FA9004560	Not Available	29	277	271	Radiographic Progressive Disease	8	5	2000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2b	YES	NO	3X	Dead	92	2014
TCGA-ZH-A8Y3	61	FEMALE	167	561	83	29.760837606224676	Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T2a	N0	M0	Stage II	0	561			WITH TUMOR		TCGA-ZH-A8Y3	1947A152-6339-4F66-B9A4-0229580F0287	oral SCC	Father	Not Available	24	-22436	561	Not Available																								Unknown	NOT HISPANIC OR LATINO																											FEMALE	167	Smoking	Not Available	No	C22.1	8160/3	C22.1	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A8Y3	WITH TUMOR	NO	YES	61	3.5	3.1	5.2	.3	9.3	306	Not Available	35.1	Unknown	None	.4	1.2	.8	0	0	8	3.1	Unknown	Cholangiocarcinoma; intrahepatic	Not Available	Not Available	Not Available	G2	YES	184000	150000	400000	Not Available	R1	Bile Duct Resection with Anastomosis	1.2	Bile duct	Micro	2010	BLACK OR AFRICAN AMERICAN	YES																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	YES	NO	ZH	Dead	83	2015
TCGA-ZH-A8Y1	74	FEMALE	165	385	78	28.650137741046834	Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T3	N1	M0	Stage IVA	1	49.0		Locoregional Recurrence	WITH TUMOR		TCGA-ZH-A8Y1	B16E9C3F-C7DF-46C2-BEE3-ECAEBBAB025F	Not Available	Not Available	Not Available	11	-27279	385	Not Available																								1	NOT HISPANIC OR LATINO																											FEMALE	165	Smoking	Not Available	No	C22.1	8160/3	C22.1	YES	3	YES	Not Available	Not Available	49	Not Available	Not Available	Locoregional Recurrence	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Yes	A8Y1	WITH TUMOR	NO	NO	74	3.5	4.6	5.0	0.0	0.7	6910	Not Available	55	Not Available	Not Available	0.6	1.0	0.8	0	Not Available	Not Available	Not Available	Not Available	Cholangiocarcinoma; intrahepatic	Not Available	Not Available	Not Available	G2	Not Available	272000	150000	440000	0.9	R1	Segmentectomy, Multiple	1.2	Bile duct	Micro	2012	WHITE	NO																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	YES	NO	ZH	Dead	78	2014
TCGA-W6-AA0T	62	FEMALE	174	656	76	25.102391333069097	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T3	N0	M0	Stage III	0	656			TUMOR FREE		TCGA-W6-AA0T	CB40327B-F3AC-4F0A-BB17-7DB2A281E354	pancreatic	Mother	1	25	-23004	Not Applicable	656																								1	NOT HISPANIC OR LATINO																											FEMALE	174	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	AA0T	TUMOR FREE	NO	YES	62	3.5	3.7	4.8	.2	.3	12	0	35	A	None	.5	1.1	.8	0	Not Available	Not Available	Not Available	0 - No Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	.9	1.2	G2	NO	212	140	450	1.2	R0	Extended Lobectomy	1.3	Bile duct	None	2013	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage III	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	W6	Alive	76	2015
TCGA-W5-AA2Z	29	FEMALE	162	1614	82	31.24523700655388	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T2	N0	M0	Stage II	0	1614			WITH TUMOR		TCGA-W5-AA2Z	20EC1CD9-7BDB-4EB9-9D20-65795580F1F5	breast cancer	Grandmother	1	24	-10659	Not Applicable	155	TCGA-W5-AA2Z-D66543;TCGA-W5-AA2Z-D66544	CDDAAF81-D81D-4D0A-9DDD-98DC9F980058;AB9BF75B-1B5E-41F4-8927-5CEEBBB41ADA	Not Available;Not Available	20;20	Not Available;Not Available	63;63	Cisplatin;Gemcitabine	Clinical Progressive Disease;Clinical Progressive Disease	10;10	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	YES;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	0	NOT HISPANIC OR LATINO	TCGA-W5-AA2Z-F66608;TCGA-W5-AA2Z-F72738	1B2F9E29-9F39-4078-849F-1F787F365E61;D401928D-2551-4A23-BD47-FCAAC61893B5	21;23	Not Available;Not Available	155;1614	Discrepancy;NO	10;11	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;Unknown	TUMOR FREE;Not Available	NO;NO	YES;YES	NO;NO	Alive;Alive	2014;2015	FEMALE	162	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	AA2Z	WITH TUMOR	NO	YES	29	3.5	4.6	5.0	0.1	0.5	495	0	55	A	None	0.6	1.1	0.8	0	0	6.0	1.6	1,2 - Portal Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	0.9	1.2	G3	NO	242	150	450	1.0	R1	Lobectomy	1.0	Bile duct	None	2010	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	W5	Alive	82	2014
TCGA-4G-AAZF	74	FEMALE	Not Available	1777	Not Available		Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T3	N0	MX	Stage III	0	1777			TUMOR FREE		TCGA-4G-AAZF	1932BC1E-2A15-4F74-978E-D49C366604A4	Not Available	Not Available	Not Available	23	-27109	Not Applicable	1777																								0	NOT HISPANIC OR LATINO																											FEMALE	Not Available	Diabetes mellitus	Not Available	No	C22.1	8160/3	C22.1	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Yes	AAZF	TUMOR FREE	NO	NO	74	3.5	3.8	4.5	.1	1.2	150.2	0	35	Not Applicable	None	.6	1.3	1	0	0	9	Not Available	3,4 - Fibrous Speta	Cholangiocarcinoma; intrahepatic	Not Available	.8	1.2	G2	NO	200000	15000	450000	1.1	R0	Segmentectomy, Single	1.2	Bile duct	None	2010	WHITE	NO																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage III	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	NO	YES	4G	Alive	Not Available	2015
TCGA-W5-AA31	71	MALE	184	10	105	31.013705103969755	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T1	N0	M0	Stage I	0	10			TUMOR FREE		TCGA-W5-AA31	2D6E20B2-82C7-4C12-92D0-93282B0A9031	Gastric Cancer;Testicular Cancer	Sister;Child	2	27	-26139	Not Applicable	10																								0	NOT HISPANIC OR LATINO	TCGA-W5-AA31-F66611	2FD211DF-3190-44BD-9D0E-FC383E8F57C7	21	Not Available	10	YES	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	184	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Yes	AA31	TUMOR FREE	NO	NO	71	Not Available	Not Available	Not Available	0.1	0.6	18	0	55	Unknown	None	0.8	1.3	0.9	0	0	6.0	4.4	0 - No Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	0.9	1.2	G3	NO	151	150	450	1.1	R0	Extended Lobectomy	1.1	Bile duct	None	2010	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	W5	Alive	105	2014
TCGA-ZH-A8Y6	41	FEMALE	152	519	89	38.52146814404432	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T1	N0	M0	Stage I	0	519			WITH TUMOR		TCGA-ZH-A8Y6	5166D82F-7B22-4101-BEA9-6056E5A74C48	uterine;uterine;breast	Mother;Grandmother;Grandmother	3	11	-14976	Not Applicable	115																								Not Available	NOT HISPANIC OR LATINO	TCGA-ZH-A8Y6-F70052	0028514C-1D43-4380-A53C-D0ACBD8841FB	26	Not Available	519	NO	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2015	FEMALE	152	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A8Y6	WITH TUMOR	Unknown	Unknown	41	3.4	3.9	5.0	0.2	0.3	29	0	35	Not Available	Not Available	0.6	1.3	1.2	0	Not Available	Not Available	Not Available	Not Available	Cholangiocarcinoma; intrahepatic	Not Available	Not Available	Not Available	G2	NO	279000	130000	400000	1.0	R0	Segmentectomy, Multiple	1.0	Bile duct	None	2013	BLACK OR AFRICAN AMERICAN	Unknown																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	YES	NO	ZH	Alive	89	2014
TCGA-W5-AA2R	77	FEMALE	158	1542	72	28.841531805800354	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T1	N0	M0	Stage I	0	1542			TUMOR FREE		TCGA-W5-AA2R	20BF79AF-3B0F-477D-B619-5597D42F5D5E	colon cancer;transitional cell cancer;colon cancer	Brother;Brother;Sister	3	23	-28367	Not Applicable	1485																								0	NOT HISPANIC OR LATINO	TCGA-W5-AA2R-F66606;TCGA-W5-AA2R-F72737	314E0F76-51E2-4634-B96C-042BC529045D;06E7ED0C-82D7-497E-8563-764D2C690E3C	21;23	Not Available;Not Available	1485;1542	YES;NO	10;11	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;Unknown	TUMOR FREE;Not Available	NO;NO	NO;NO	NO;NO	Alive;Alive	2014;2015	FEMALE	158	Smoking	Not Available	No	C22.1	8160/3	C22.1	YES	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	AA2R	TUMOR FREE	NO	NO	77	3.5	4.2	5.0	0.1	0.5	11	0	55	A	None	0.6	1.1	0.9	0	0	6.0	3.6	0 - No Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	0.9	1.2	G3	NO	272	150	450	0.8	R0	Segmentectomy, Multiple	1.0	Bile duct	None	2006	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	W5	Alive	72	2014
TCGA-3X-AAVC	72	FEMALE	159	709	104	41.13761322732487	Cholangiocarcinoma; hilar/perihilar	Bile duct	Alive	T1	N0	M0	Stage I	0	709			TUMOR FREE		TCGA-3X-AAVC	FF4131C9-537C-46CC-B495-9AF60D431F5E	Not Available	Not Available	Not Available	11	-26493	Not Applicable	371																								0	NOT HISPANIC OR LATINO	TCGA-3X-AAVC-F67116	A9A1864D-EEEE-40BB-8071-08D4A0F00FA4	30	Not Available	709	NO	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	159	Other	Pancreatitis	No	C24.0	8160/3	C24.0	YES	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	AAVC	TUMOR FREE	NO	NO	72	3.3	2.4	4.8	0	0.5	Not Available	Not Available	Not Available	B	None	0.4	1.1	0.8	0	Not Available	Not Available	Not Available	1,2 - Portal Fibrosis	Cholangiocarcinoma; hilar/perihilar	Not Available	0.9	1.1	G3	NO	255	150	400	1.1	R0	Segmentectomy, Multiple	1.2	Bile duct	None	2012	WHITE	NO																			Unknown	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	3X	Alive	104	2014
TCGA-W5-AA2M	49	MALE	180	540	79	24.382716049382715	Cholangiocarcinoma; hilar/perihilar	Bile duct	Dead	T3	N0	M1	Stage IVB	1	157.0	Other, specify	Extrahepatic Recurrence	WITH TUMOR		TCGA-W5-AA2M	BEC2CF62-44A2-42E5-8E10-440AAD69ED77	Not Available	Not Available	Not Available	25	-17989	540	Not Available																								0	Unknown																											MALE	180	No History of Primary Risk Factors	Not Available	No	C24.0	8160/3	C24.0	YES	11	YES	NO	Not Available	157	Not Available	Other, specify	Extrahepatic Recurrence	peritoneum, lungs	NO	NO	NO	Not Available	YES	No	AA2M	WITH TUMOR	NO	NO	49	3.5	4.3	5	.1	1.1	138	0	40	A	None	.9	1.4	1	0	0	6	4.5	0 - No Fibrosis	Cholangiocarcinoma; hilar/perihilar	lobectomy and extrahepatic bile duct regional lymphadenectomy	.8	1.2	G2	NO	355	150	450	.9	R0	Other (specify)	1	Bile duct	None	2006	Unknown	NO																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N0	T3	NO	YES	W5	Dead	79	2015
TCGA-W5-AA2W	31	FEMALE	167	924	91	32.62935207429452	Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T2a	N1	M0	Stage IVA	1	237.0	Liver	Intrahepatic Recurrence	WITH TUMOR		TCGA-W5-AA2W	1D136284-BDF5-498E-9506-4893801A337C	Not Available	Not Available	Not Available	24	-11438	924	Not Available																								0	NOT HISPANIC OR LATINO																											FEMALE	167	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	5	YES	NO	Not Available	237	Not Available	Liver	Intrahepatic Recurrence	Not Available	NO	NO	NO	Not Available	YES	No	AA2W	WITH TUMOR	NO	NO	31	3.5	3.7	5.0	0.1	0.4	104	0	55	A	None	0.6	1.1	0.6	0	Not Available	Not Available	Not Available	0 - No Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	0.9	1.2	G3	NO	217	150	450	1.1	R0	Segmentectomy, Multiple	1.0	Bile duct	None	2010	WHITE	NO																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	NO	YES	W5	Dead	91	2014
TCGA-3X-AAVB	70	FEMALE	170	402	76	26.29757785467128	Cholangiocarcinoma; distal	Bile duct	Alive	T3	N1	M1	Stage IVB	0	402			Unknown		TCGA-3X-AAVB	3824CD6D-C85C-4B21-819A-932D1AFEF976	Not Available	Not Available	Not Available	9	-25819	Not Applicable	368																								0	NOT HISPANIC OR LATINO	TCGA-3X-AAVB-F67237	DD08BFBD-B3F1-43CE-B884-C522CE557D03	3	Not Available	402	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	Unknown	Unknown	Unknown	Alive	2014	FEMALE	170	No History of Primary Risk Factors	Not Available	No	C24.0	8160/3	C24.0	YES	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	AAVB	Unknown	Unknown	Unknown	70	3.3	4.3	4.8	0	1.7	322	0	35	A	None	0.4	1.1	0.9	0	Not Available	Not Available	Not Available	Unknown	Cholangiocarcinoma; distal	Not Available	0.9	1.1	G1	YES	215	150	400	1.1	R0	Pancreaticoduodenectomy (Whipple Resection)	1.2	Bile duct	None	2012	WHITE	Unknown																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1	N1	T3	NO	YES	3X	Alive	76	2014
TCGA-W5-AA36	51	FEMALE	165	1402	68	24.977043158861342	Cholangiocarcinoma; hilar/perihilar	Bile duct	Dead	T3	N0	M1	Stage IV	1	362.0	Liver	Intrahepatic Recurrence	WITH TUMOR		TCGA-W5-AA36	F2D42E03-CA8D-4B57-AE39-0CC8F37B1B67	Not Available	Not Available	Not Available	27	-18882	1402	Not Available	TCGA-W5-AA36-D66586;TCGA-W5-AA36-D66587	142FCDBF-2454-419D-8C30-0163EF88F077;13B1D563-8D8D-499C-B749-C67DE30D4DE3	Not Available;Not Available	21;21	76;76	41;41	Gemcitabine;Capecitabine	Stable Disease;Stable Disease	10;10	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	0	NOT HISPANIC OR LATINO																											FEMALE	165	No History of Primary Risk Factors	Not Available	Yes	C22.1	8160/3	C22.1	YES	5	YES;YES	NO;NO	Not Available;Not Available	362;362	Not Available;Not Available	Liver;Lung	Intrahepatic Recurrence;Extrahepatic Recurrence	Not Available;Not Available	NO;NO	NO;NO	NO;NO	Not Available;Not Available	YES	No	AA36	WITH TUMOR	NO	YES	51	3.5	4.6	5.0	0.1	0.8	1	0	55	A	None	0.6	1.1	0.8	0	0	6	14	0 - No Fibrosis	Cholangiocarcinoma; hilar/perihilar	Not Available	0.8	1.2	G3	NO	197	150	450	1.3	R0	Extended Lobectomy	1.0	Bile duct	None	2008	WHITE	NO																			Unknown	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N0	T3	NO	YES	W5	Dead	68	2014
TCGA-ZH-A8Y4	58	MALE	183	741	88	26.277285078682553	Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T1	N0	M0	Stage I	1	281.0		Locoregional Recurrence	WITH TUMOR		TCGA-ZH-A8Y4	95B69517-4971-450E-9ED0-43BC8B2C0534	Melanoma	Mother	1	11	-21503	741	Not Available	TCGA-ZH-A8Y4-D57457	0C3D3AAA-8392-4A62-BD01-C0EA99C146CF	Not Available	11	162	70	Gemzar	Partial Response	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	NOT HISPANIC OR LATINO																											MALE	183	Diabetes mellitus;Smoking	Not Available	No	C22.1	8160/3	C22.1	YES	3	YES	NO	Not Available	281	Not Available	Not Available	Locoregional Recurrence	Not Available	NO	NO	Not Available	Not Available	YES	Yes	A8Y4	WITH TUMOR	NO	YES	58	3.5	4.2	5.0	0.0	0.3	27	Not Available	55	Not Available	Not Available	0.7	1.3	0.9	0	0.0	10.0	6.0	Not Available	Cholangiocarcinoma; intrahepatic	Not Available	Not Available	Not Available	G3	NO	208000	150000	440000	1.1	R1	Segmentectomy, Multiple	1.2	Bile duct	None	2010	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	YES	NO	ZH	Dead	88	2014
TCGA-W7-A93N	Not Available	MALE	183	1441	83	24.784257517393772	Cholangiocarcinoma; distal	Bile duct	Alive	T3	N1	MX	Stage IIB	1				WITH TUMOR		TCGA-W7-A93N	D64D8A1B-B31F-4CBB-A586-5EC7F058F0DE	lung	Father	1	25	Not Available	Not Applicable	1441																								Not Available	NOT HISPANIC OR LATINO																											MALE	183	Smoking	Not Available	No	C24.0	8160/3	C24.0	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	No	A93N	WITH TUMOR	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Evaluated	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Cholangiocarcinoma; distal	Not Available	Not Available	Not Available	G3	YES	Not Available	Not Available	Not Available	Not Available	R0	Pancreaticoduodenectomy (Whipple Resection)	Not Available	Bile duct	Micro	2010	WHITE	Unknown																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T3	NO	YES	W7	Alive	83	2015
TCGA-ZH-A8Y7	59	MALE	180	755	73	22.530864197530864	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T3	N0	M1	Stage IVB	1	301.0		Intrahepatic Recurrence	WITH TUMOR		TCGA-ZH-A8Y7	37D60DF9-2FA5-433B-9E54-DCCB5ED5A638	Not Available	Not Available	Not Available	25	-21880	Not Applicable	755																								Unknown	Unknown																											MALE	180	Smoking;Other	smokeless tobacco	No	C22.1	8160/3	C22.1	YES	11	YES	NO	Not Available	301	Not Available	Not Available	Intrahepatic Recurrence	Not Available	YES	NO	NO	Not Available	YES	Yes	A8Y7	WITH TUMOR	NO	NO	59	3.5	2.4	5	.2	.3	39.1	0	36.9	Unknown	None	.7	1.3	.8	0	0	10	6.8	1,2 - Portal Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	Not Available	Not Available	G3	YES	187000	130000	400000	1.1	R1	Segmentectomy, Multiple	1.3	Bile duct	Micro	2013	WHITE	NO																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1	N0	T3	YES	NO	ZH	Alive	73	2015
TCGA-W5-AA2G	62	FEMALE	159	1976	52	20.568806613662435	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T1	N0	M0	Stage I	0	1976			TUMOR FREE		TCGA-W5-AA2G	22BF93B3-C8DC-4669-862F-3E4AE478849B	Testicular;Prostate;Leukemia	Father;Father;Father	1	22	-22933	Not Applicable	1976																								1	NOT HISPANIC OR LATINO	TCGA-W5-AA2G-F66604	966981B5-E87B-4475-AA05-27E5E99C76B8	21	Not Available	1976	YES	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	159	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	AA2G	TUMOR FREE	NO	NO	62	3.5	4.1	5.0	0.1	0.7	71	0	55	A	None	0.6	1.1	0.7	0	0	6.0	2.5	0 - No Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	0.8	1.2	G3	NO	159	150	450	1.2	R0	Extended Lobectomy	1.0	Bile duct	None	2008	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	W5	Alive	52	2014
TCGA-W5-AA30	82	MALE	188	1153	102	28.85921231326392	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T1	N0	M0	Stage I	0	1153			TUMOR FREE		TCGA-W5-AA30	B4F7F9E4-5FC5-4461-8E0B-0B6C384863C6	colon cancer	Brother	1	24	-30039	Not Applicable	1079																								0	NOT HISPANIC OR LATINO	TCGA-W5-AA30-F66610;TCGA-W5-AA30-F72739	B7D96997-EC27-438D-95D7-16B1817F93FB;FEC62CA3-F195-4DD2-93D3-15B9BECE9E9E	21;23	Not Available;Not Available	1079;1153	YES;NO	10;11	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;Unknown	TUMOR FREE;Not Available	NO;NO	NO;NO	NO;NO	Alive;Alive	2014;2015	MALE	188	Smoking	Not Available	No	C22.1	8160/3	C22.1	YES	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	AA30	TUMOR FREE	NO	NO	82	3.5	4.3	5.0	0.1	0.9	265	0	55	Not Available	None	0.8	1.3	1.0	0	0	6.0	3.7	0 - No Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	0.8	1.2	G3	NO	134	150	450	1.0	R0	Lobectomy	1.0	Bile duct	None	2010	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	W5	Alive	102	2014
TCGA-ZH-A8Y2	59	FEMALE	173	701	80	26.72992749507167	Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T1	NX	M0	Stage I	1	198.0		Locoregional Recurrence	WITH TUMOR		TCGA-ZH-A8Y2	47A9EF9B-04F0-4E8D-BFDB-0846BA30D08B	Unknown;Unknown;Colon	Sister;Sister;Brother	3	11	-21743	701	Not Available																								Not Available	NOT HISPANIC OR LATINO																											FEMALE	173	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	3	YES	YES	245	198	Not Available	Not Available	Locoregional Recurrence	Not Available	NO	YES	Not Available	R1	YES	No	A8Y2	WITH TUMOR	NO	NO	59	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	0.0	10.0	7.8	Not Available	Cholangiocarcinoma; intrahepatic	Not Available	Not Available	Not Available	G2	NO	Not Available	Not Available	Not Available	Not Available	R0	Segmentectomy, Multiple	Not Available	Bile duct	Micro	2011	BLACK OR AFRICAN AMERICAN	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1	YES	NO	ZH	Dead	80	2014
TCGA-W7-A93O	Not Available	FEMALE	170	180	54	18.685121107266436	Cholangiocarcinoma; distal	Bile duct	Alive	T3	N1	MX	Stage IIB	0	180			TUMOR FREE		TCGA-W7-A93O	15850852-5979-419D-AE38-76FFD0E9D7E8	bowel;oesphagus	Mother;Brother	2	25	Not Available	Not Applicable	180																								Not Available	NOT HISPANIC OR LATINO																											FEMALE	170	No History of Primary Risk Factors	Not Available	No	C25.0	8160/3	C25.0	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A93O	TUMOR FREE	NO	YES	Not Available	Not Available	Not Available	Not Available	78	2.1	Not Available	Not Available	Not Available	Not Applicable	Not Evaluated	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Cholangiocarcinoma; distal	Not Available	Not Available	Not Available	G3	NO	Not Available	393	491	1	R0	Pancreaticoduodenectomy (Whipple Resection)	96	Bile duct	Micro	2012	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T3	NO	YES	W7	Alive	54	2015
TCGA-W5-AA33	60	MALE	192	1449	128	34.72222222222222	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T1	N0	M0	Stage I	0	1449			TUMOR FREE		TCGA-W5-AA33	5FB3AFFA-3661-48E8-A1CC-B533C862E8C5	Prostate Cancer;Breast Cancer and skin cancer	Father;Grandmother	2	27	-22090	Not Applicable	1070																								1	NOT HISPANIC OR LATINO	TCGA-W5-AA33-F72740	360AEC5C-463F-4444-A4BE-DA32628D8F49	23	Not Available	1449	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	NO	NO	NO	Alive	2015	MALE	192	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	AA33	TUMOR FREE	NO	NO	60	3.5	4.4	5.0	0.1	0.5	17	0	55	A	None	0.8	1.3	1.0	0	0	6.0	2.0	0 - No Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	0.8	1.2	G3	NO	231	150	450	1.1	R0	Segmentectomy, Multiple	1.0	Bile duct	None	2011	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	W5	Alive	128	2014
TCGA-YR-A95A	52	MALE	177	26	77	24.57786715184015	Cholangiocarcinoma; hilar/perihilar	Bile duct	Dead	T2	NX	M1	Stage IV	1	17.0	Other, specify	New Primary Tumor	WITH TUMOR		TCGA-YR-A95A	779CE92D-1ABD-44FC-9021-EDA4D7F08FFF	Brain tumor	Sister	Not Available	23	-19292	26	Not Available																								Unknown	Not Evaluated																											MALE	177	No History of Primary Risk Factors	Not Available	No	C24.0	8160/3	C24.0	YES	10	NO	NO	Not Available	17	Not Available	Other, specify	New Primary Tumor	Adrenal gland	NO	NO	NO	Not Available	YES	No	A95A	WITH TUMOR	NO	NO	52	3.4	4.3	4.8	Not Available	2	18.15	0	39	Not Available	Not Evaluated	0.7	1.2	0.8	0	0	15	1.38	Not Available	Cholangiocarcinoma; hilar/perihilar	Not Available	0	1.2	G2	YES	240000	125000	450000	0.9	R1	Segmentectomy, Multiple	Not Available	Bile duct	Unknown	2009	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	NX	T2	NO	YES	YR	Dead	77	2014
TCGA-W5-AA2X	67	MALE	167	271	88	31.553659148768332	Cholangiocarcinoma; hilar/perihilar	Bile duct	Dead	T2b	N1	M1	Stage IVB	0	271			Unknown		TCGA-W5-AA2X	6E534DD3-81AC-4575-AB1E-02C21E10916D	breast	Sister	1	24	-24797	271	Not Available																								0	NOT HISPANIC OR LATINO																											MALE	167	No History of Primary Risk Factors	Not Available	No	C24.0	8160/3	C24.0	YES	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	AA2X	Unknown	NO	NO	67	3.5	4.0	5.0	0.1	0.7	203	0	55	A	None	0.8	1.3	0.8	0	0	6.0	4.0	1,2 - Portal Fibrosis	Cholangiocarcinoma; hilar/perihilar	Not Available	0.9	1.2	G4	NO	541	150	450	1.0	RX	Pancreaticoduodenectomy (Whipple Resection)	1.0	Bile duct	Micro	2010	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1	N1	T2b	NO	YES	W5	Dead	88	2014
TCGA-W5-AA2J	66	FEMALE	157	916	63	25.55884620065723	Cholangiocarcinoma; hilar/perihilar	Bile duct	Alive	T4	N0	M0	Stage IVA	0	916			TUMOR FREE		TCGA-W5-AA2J	3F7E0CBF-E48C-410A-9138-BE9B373FEF73	Not Available	Not Available	Not Available	25	-24140	Not Applicable	916																								0	NOT HISPANIC OR LATINO																											FEMALE	157	Primary sclerosing cholangitis	Not Available	No	C22.1	8160/3	C22.1	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	AA2J	TUMOR FREE	NO	NO	66	3.5	4.1	5	.1	1	52	0	55	A	Not Evaluated	.6	1.1	.7	0	0	6	Not Available	6 - Established Cirrhosis	Cholangiocarcinoma; hilar/perihilar	Not Available	.8	1.2	G2	NO	172	150	450	.9	R0	Lobectomy	1	Bile duct	None	2012	WHITE	NO																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	NO	YES	W5	Alive	63	2015
TCGA-W5-AA2H	70	FEMALE	162	1077	71	27.053802773967384	Cholangiocarcinoma; distal	Bile duct	Alive	T3	N0	M0	Stage III	0	1077			TUMOR FREE		TCGA-W5-AA2H	BC15CEC4-1F82-47FE-AE69-3853194FAB7E	colon/rectal cancer;lung	Father;Sister	2	22	-25775	Not Applicable	635	TCGA-W5-AA2H-D66540	81CA8572-5288-4103-975B-F4EB32778652	Not Available	20	271	59	gemcitabine	Complete Response	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	NOT HISPANIC OR LATINO	TCGA-W5-AA2H-F72736	E11125EE-82E7-4DE9-A596-AE6371CF111A	23	Not Available	1077	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	NO	YES	NO	Alive	2015	FEMALE	162	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	AA2H	TUMOR FREE	NO	YES	70	3.5	4.3	5.0	0.1	1.2	44	0	55	A	None	0.6	1.1	0.9	0	0	6.0	3.1	0 - No Fibrosis	Cholangiocarcinoma; distal	Not Available	0.8	1.2	G3	NO	369	150	450	0.9	R0	Pancreaticoduodenectomy (Whipple Resection)	1.0	Bile duct	None	2012	WHITE	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage III	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	W5	Alive	71	2014
TCGA-3X-AAV9	72	MALE	169	339	52	18.206645425580337	Cholangiocarcinoma; intrahepatic	Bile duct	Dead	T1	N0	M0	Stage I	1	216.0	Liver	Locoregional Recurrence	WITH TUMOR		TCGA-3X-AAV9	41B97B11-ACAA-4FBC-B3B0-0ABC1BCAC13B	Unknown;Probably Kidney Cancer	Brother;Brother	2	9	-26349	339	Not Available	TCGA-3X-AAV9-D59949;TCGA-3X-AAV9-D59950	24CDD866-74A2-4B6F-813B-CB7C616A642A;51CC30E9-BA70-49F4-8F12-C5419751557F	Not Available;Not Available	26;26	326;326	253;253	Gemcitabine;Cisplatin	Clinical Progressive Disease;Clinical Progressive Disease	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	0	NOT HISPANIC OR LATINO																											MALE	169	Ulcerative colitis	Not Available	No	C22.1	8160/3	C22.1	YES	7	YES;YES	NO;NO	Not Available;Not Available	216;216	Not Available;Not Available	Liver;Lung	Locoregional Recurrence;Extrahepatic Recurrence	Not Available;Not Available	NO;NO	NO;NO	NO;NO	Not Available;Not Available	YES	Yes	AAV9	WITH TUMOR	NO	YES	72	3.3	2.7	4.8	0	0.2	538	0	35	B	None	0.6	1.4	1.1	0	Not Available	Not Available	Not Available	0 - No Fibrosis	Cholangiocarcinoma; intrahepatic	Right Hepatectomy	Not Available	Not Available	G2	YES	254	150	400	Not Available	R0	Other (specify)	1.4	Bile duct	None	2010	ASIAN	NO																			YES	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	YES	NO	3X	Dead	52	2014
TCGA-4G-AAZT	62	MALE	175	420	65	21.224489795918366	Cholangiocarcinoma; intrahepatic	Bile duct	Alive	T1	N0	M0	Stage I	0	420			TUMOR FREE		TCGA-4G-AAZT	B10C64C2-7FD2-4210-B975-034AFFB14B57	Not Available	Not Available	Not Available	28	-22777	Not Applicable	206																								0	NOT HISPANIC OR LATINO	TCGA-4G-AAZT-F72743	1D102657-C14C-4702-B3F3-DA8CA28F9BBF	24	Not Available	420	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	NO	NO	NO	Alive	2015	MALE	175	No History of Primary Risk Factors	Not Available	No	C22.1	8160/3	C22.1	YES	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	AAZT	TUMOR FREE	NO	NO	62	3.4	4.4	4.8	0.3	0.6	52.8	0	35.0	Unknown	None	0.6	1.1	0.6	0	0	9.0	2	1,2 - Portal Fibrosis	Cholangiocarcinoma; intrahepatic	Not Available	10	13	G2	NO	354000	140000	450000	11.7	R0	Segmentectomy, Multiple	1.2	Bile duct	None	2013	WHITE	NO																			NO	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	4G	Alive	65	2014
